Anti-angiogenic control is provided by miR-138-5p (HIF-1α/VEGFA blockade) and miR-101, which thwarts vascular mimicry by targeting TGFβR1/SMAD2 in tumor cells and SDF1 in CAFs [52,53,54]. Here, VEGFA is linked to neoplasm.